The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma.

NCT04065282 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Sintilimab
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

First Affiliated Hospital of Zhejiang University